ATE161174T1 - Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung - Google Patents

Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung

Info

Publication number
ATE161174T1
ATE161174T1 AT94911799T AT94911799T ATE161174T1 AT E161174 T1 ATE161174 T1 AT E161174T1 AT 94911799 T AT94911799 T AT 94911799T AT 94911799 T AT94911799 T AT 94911799T AT E161174 T1 ATE161174 T1 AT E161174T1
Authority
AT
Austria
Prior art keywords
solid preparation
production
release solid
high release
active agent
Prior art date
Application number
AT94911799T
Other languages
English (en)
Inventor
Jean Paul Remon
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of ATE161174T1 publication Critical patent/ATE161174T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94911799T 1993-04-22 1994-04-21 Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung ATE161174T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9300407A BE1006990A5 (nl) 1993-04-22 1993-04-22 Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.

Publications (1)

Publication Number Publication Date
ATE161174T1 true ATE161174T1 (de) 1998-01-15

Family

ID=3886999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911799T ATE161174T1 (de) 1993-04-22 1994-04-21 Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung

Country Status (12)

Country Link
US (1) US6368634B1 (de)
EP (1) EP0695172B1 (de)
JP (1) JP2960169B2 (de)
AT (1) ATE161174T1 (de)
AU (1) AU6421594A (de)
BE (1) BE1006990A5 (de)
CA (1) CA2161016A1 (de)
DE (1) DE69407404T2 (de)
DK (1) DK0695172T3 (de)
ES (1) ES2113095T3 (de)
GR (1) GR3026338T3 (de)
WO (1) WO1994023700A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4318577A1 (de) * 1993-06-04 1994-12-08 Merck Patent Gmbh Schmiermittelfreie, arzneimittelhaltige Tabletten
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー.,インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
EP0969817A1 (de) * 1997-10-07 2000-01-12 Fuisz Technologies Ltd. Darreichungsformen mit verbesserten freisetzungseigenschaften
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
AU2003211267A1 (en) * 2002-02-27 2003-09-09 Shionogi And Co., Ltd. Solid preparations with improved absorbability of hardly water-soluble drug
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
EP2051696A2 (de) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stabile flüssige levetiracetam-zusammensetzungen und verfahren
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (de) 2018-07-20 2026-04-01 Lipocine Inc. Orale pharmazeutische zusammensetzung mit testosterontridecanoat und/oder testosterondodecanoat zur behandlung von lebererkrankungen
WO2020262536A1 (en) 2019-06-26 2020-12-30 Ricoh Company, Ltd. Instantly soluble particle and method for producing the same
JPWO2020261619A1 (de) 2019-06-26 2020-12-30

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1148802A (en) * 1965-06-18 1969-04-16 Eastman Kodak Co Microcrystalline cellulose granules containing useful oils
CH523017A (de) * 1969-11-21 1972-05-31 Agripat Sa Schädlingsbekämpfungsmittel
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
GB1367608A (en) * 1973-03-09 1974-09-18 Biolog Concepts Inc Oral pharmaceutical dosage form
USRE33963E (en) * 1981-10-29 1992-06-16 Bayer Aktiengesellschaft Solid rapidly released medicament preparations containing dihydropyridines, and processes for their preparation
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DD249186A1 (de) * 1986-05-26 1987-09-02 Univ Halle Wittenberg Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法

Also Published As

Publication number Publication date
ES2113095T3 (es) 1998-04-16
WO1994023700A1 (en) 1994-10-27
DE69407404T2 (de) 1998-07-02
BE1006990A5 (nl) 1995-02-07
JP2960169B2 (ja) 1999-10-06
EP0695172B1 (de) 1997-12-17
DE69407404D1 (de) 1998-01-29
EP0695172A1 (de) 1996-02-07
GR3026338T3 (en) 1998-06-30
DK0695172T3 (da) 1998-08-24
AU6421594A (en) 1994-11-08
JPH09500093A (ja) 1997-01-07
CA2161016A1 (en) 1994-10-27
US6368634B1 (en) 2002-04-09

Similar Documents

Publication Publication Date Title
DE69407404D1 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
AU560829B2 (en) Continuous release pharmaceutical compositions
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
DE69006947D1 (de) Stabilisiertes FGF-Mittel und dessen Herstellung.
MY129941A (en) Novel dihydro-isoquinoline derivatives
AU8142594A (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ES2138584T3 (es) Sistema de suministro de farmacos que implica la reaccion entre una proteina o un polipeptido y un polimero biodegradable hidrofobo.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
DK74187A (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
ITRM920590A0 (it) Sistema per la realizzazione distrutture in fibra di carbonio, e procedimento per detto, particolarmente idoneo per applicazioni aeronautiche.
ATE221773T1 (de) Formulierungen mit gesteuerter freisetzung
UY24210A1 (es) Composicion de gel o de barra antitranspirante libre de pegajosidad, clara o translucida y metodo de fabricacion
IS1620B (is) Aðferð til framleiðslu á lyfjablöndum sem innihalda nifedipine
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE69431162D1 (en) Fenbendazolformulierungen
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ES8601756A1 (es) Metodo de fabricar una estructura compuesta coherente.
AU8375891A (en) Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
ATE147742T1 (de) 8-alpha-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
ATE262596T1 (de) Pulverförmige dextrose und verfahren zur herstellung derselben
ATE115565T1 (de) 2-halogensubstituierte n-indolylethyl- sulfonsäureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
JPS53114629A (en) Data highway system

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee